The Effect of Standard vs. Shorter Filter Lifespan During Continuous Renal Replacement Therapy

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial compares standard filter replacement schedules against shorter ones during continuous renal replacement therapy — can you explain how changing the filter more frequently might affect my kidney treatment, and what the potential risks or benefits of each approach are?
2. 2Since this trial is listed as 'not yet recruiting,' does that mean it's not an option for me right now, and is there a standard filter replacement schedule already being used in my care that I should know about?
3. 3The trial is measuring how well the medical team follows the filter change schedule — what does that tell us about how experimental or uncertain this protocol still is, and should that factor into my decision about participating?
4. 4Because this is listed as Phase NA, meaning it's more of a procedural or protocol study rather than a traditional drug trial, how does that affect what's already known about safety, and what risks — if any — would I be taking on by being part of it?
5. 5Are there standard continuous renal replacement therapy approaches already proven for my specific situation that I should consider before this trial becomes available, and how would you help me decide between waiting for this study or proceeding with current standard care?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.